Hydroxyethylidene diphosphonate (HEDP) was prepared and labeled with rhenium-188. Its lyophilized kit was developed for instant preparing of Re-188-HEDP. Re-188-HEDP showed high focile uptake in normal mice (> 30% ID/g at carrier co-injection) in BABLC/SPF mice. High quality single photon emission computed tomography (SPECT) image of New Zealand rabbit was obtained at 4 h after intravenous injection of 74 MBq radiotracer. The lyophilized HEDP kit affords the new opportunity for routine clinical application in bone metastases therapy.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000348411100009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=8e1609b174ce4e31116a60747a...
Therapeutic phosphonate-based radiopharmaceuticals radiolabeled with beta, alpha and conversion elec...
Diethylenetriaminepentaacetic acid neolactosyl human serum albumin (DTPA-LSA) was prepared and label...
Hendrikse, N.H. [Promotor]Heine, R. ter [Copromotor]Klerk, J.M.H. de [Copromotor]Bloemendal, H.J. [C...
Hydroxyethylidene diphosphonate (HEDP) was prepared and labeled with rhenium-188. Its lyophilized ki...
Systemic use of radiopharmaceuticals is a recognized alternative method for the treatment of pain in...
The purpose of this study is to prepare 99mTc-HEDTMP [N-(2-hydroxyethyl) ethlenediamine-1,1,2-tri (m...
Pentavalent rhenium-188 dimercaptosuccinic acid [Re-188(V)DMSA] is a beta-emitting analogue of Tc-99...
INTRODUCTION: (188)Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for ...
Radionuclide bone metastases therapy is a major achievement of nuclear medicine. Development of less...
Introduction: 188Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for tr...
Rhemium-186-1-hydroxyethylidene-1,1-diphosphonate ( 186Re-HEDP) has been used for the palliation of ...
Objectives. The present study was initiated to explore the effects of hydroxyethylidene diphosphonat...
The nuclear properties of 186gRe make it a useful agent for radionuclide therapy and imaging. The co...
Re-188 is a beta(-) (Emax = 2.12 MeV) and gamma (155 keV) emitter. Since its chemistry is similar to...
MDP (methylenediphosphonate) and HEDP (hydroxyethylidene diphosphonate), both diphosphonates, and ED...
Therapeutic phosphonate-based radiopharmaceuticals radiolabeled with beta, alpha and conversion elec...
Diethylenetriaminepentaacetic acid neolactosyl human serum albumin (DTPA-LSA) was prepared and label...
Hendrikse, N.H. [Promotor]Heine, R. ter [Copromotor]Klerk, J.M.H. de [Copromotor]Bloemendal, H.J. [C...
Hydroxyethylidene diphosphonate (HEDP) was prepared and labeled with rhenium-188. Its lyophilized ki...
Systemic use of radiopharmaceuticals is a recognized alternative method for the treatment of pain in...
The purpose of this study is to prepare 99mTc-HEDTMP [N-(2-hydroxyethyl) ethlenediamine-1,1,2-tri (m...
Pentavalent rhenium-188 dimercaptosuccinic acid [Re-188(V)DMSA] is a beta-emitting analogue of Tc-99...
INTRODUCTION: (188)Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for ...
Radionuclide bone metastases therapy is a major achievement of nuclear medicine. Development of less...
Introduction: 188Rhenium-HEDP is an effective bone-targeting therapeutic radiopharmaceutical, for tr...
Rhemium-186-1-hydroxyethylidene-1,1-diphosphonate ( 186Re-HEDP) has been used for the palliation of ...
Objectives. The present study was initiated to explore the effects of hydroxyethylidene diphosphonat...
The nuclear properties of 186gRe make it a useful agent for radionuclide therapy and imaging. The co...
Re-188 is a beta(-) (Emax = 2.12 MeV) and gamma (155 keV) emitter. Since its chemistry is similar to...
MDP (methylenediphosphonate) and HEDP (hydroxyethylidene diphosphonate), both diphosphonates, and ED...
Therapeutic phosphonate-based radiopharmaceuticals radiolabeled with beta, alpha and conversion elec...
Diethylenetriaminepentaacetic acid neolactosyl human serum albumin (DTPA-LSA) was prepared and label...
Hendrikse, N.H. [Promotor]Heine, R. ter [Copromotor]Klerk, J.M.H. de [Copromotor]Bloemendal, H.J. [C...